SANGAMO THERAPEUTICS, INC. (SGMOQ) Operating margin 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) operating margin by fiscal year — reported operating income divided by reported revenue.
-306.5%FY2025 · since FY2016: -374.2% → -306.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -306.5% | -126.7 pp |
| FY2024 | -179.9% | -24.4 pp |
| FY2023 | -155.5% | +25.4 pp |
| FY2022 | -180.8% | -15.2 pp |
| FY2021 | -165.6% | -56.0 pp |
| FY2020 | -109.6% | -6.9 pp |
| FY2019 | -102.7% | -11.3 pp |
| FY2018 | -91.4% | +62.8 pp |
| FY2017 | -154.1% | +220.1 pp |
| FY2016 | -374.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice